The estimated Net Worth of Michael D Dicandilo is at least $60.3 Milion dollars as of 2 May 2011. Michael Dicandilo owns over 245,258 units of Amerisource Bergen stock worth over $60,285,381 and over the last 21 years Michael sold ABC stock worth over $0.
Michael has made over 5 trades of the Amerisource Bergen stock since 2006, according to the Form 4 filled with the SEC. Most recently Michael exercised 245,258 units of ABC stock worth $3,448,327 on 2 May 2011.
The largest trade Michael's ever made was exercising 331,570 units of Amerisource Bergen stock on 19 November 2009 worth over $5,464,274. On average, Michael trades about 53,626 units every 113 days since 2004. As of 2 May 2011 Michael still owns at least 334,956 units of Amerisource Bergen stock.
You can see the complete history of Michael Dicandilo stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is 1300 MORRIS DRIVE, , CHESTERBROOK, PA, 19087.
Over the last 21 years, insiders at Amerisource Bergen have traded over $4,389,593,610 worth of Amerisource Bergen stock and bought 18,610 units worth $1,659,872 . The most active insiders traders include Boots Alliance, Inc.Walgree..., Lon R Greenberg a Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of $13,111,903. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth $813,987.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: